Comparative analysis of the clinical effects of moxifloxacin and levofloxacin in the treatment of urinary tract infections
莫西沙星与左氧氟沙星治疗泌尿系统感染的临床效果对比分析

摘要

目的 探讨在泌尿系统感染中应用莫西沙星与左氧氟沙星治疗的效用价值。方法 此次实验共选取128例患者进行研究分析，均为泌尿系统感染病症，采取摇号方式根据治疗方式的区别进行分组，应用左氧氟沙星药物的对照组与给予莫西沙星药物的观察组各64例患者，对比两组临床效果。结果 经实验结果表明，两组患者在临床疗效、细菌总清除率以及不良反应发生率方面经对比无显著差异（P＞0.05）。但比较两组成本-疗效后可见，相比对照组，观察组明显较高，具有显著优势（P＜0.05）。结论 在泌尿系统感染治疗中，左氧氟沙星与莫西沙星药物均可有效控制病情发展，改善患者各症状，但从经济角度来看，几近相同的疗效左氧氟沙星药物的优势更为明显，主要是因其成本较高相比莫西沙星较低。

Abstract

Objective To explore the utility value of applying moxifloxacin and levofloxacin treatment in urinary system infection.
Methods: A total of 128 patients were selected for research and analysis in this experiment, all of them were urinary system infections, and they were grouped according to the difference of treatment modes by shaking the number, and the control group applying levofloxacin and the observation group given moxifloxacin were each 64 patients, comparing the clinical effects of the two groups.
Results: The experimental results showed that there was no significant difference between the two groups in terms of clinical efficacy, total bacterial clearance rate and the incidence of adverse reactions upon comparison (P＞0.05). However, after comparing the cost-effectiveness of the two groups, it can be seen that compared with the control group, the observation group is significantly higher, with a significant advantage (P < 0.05).
Conclusion  : In the treatment of urinary tract infections, levofloxacin and moxifloxacin can effectively control the development of the disease and improve the symptoms of patients, but from the economic point of view, nearly the same efficacy of levofloxacin is more obvious, mainly because of its higher cost compared to moxifloxacin is lower.